Status
Conditions
Treatments
About
This is a monocentric prospective study for the collection of biological samples (blood and biopsies) to be used for in vitro biomarker assay(s) performed to identify predictive markers of response to biological treatments in inflammatory bowel disease (IBD).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Patients under guardianship / curators
Following Situations
Pregnant or lactating women.
Loading...
Central trial contact
Matthieu Allez, MDPhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal